|
|
| |
| |
 |
|
|
 |
|
 |
| |
|
OSTEORISE
Risedronate Sodium
|
|
|
|
|
FORMULATIONS
|
|
TABS. 5mg, 35mg
|
| INDICATIONS |
|
To prevent and treat osteoporosis in postmenopausal
women.
To prevent and treat osteoporosis in men and women
caused by treatment with steroid medicines such as prednisone.
To treat Paget’s disease of bone.
|
Go
Back
|
|
|
|
|
| |
©
2006, CCL Pharmaceuticals |
|